nifekalant hydrochloride has been researched along with pinacidil in 1 studies
| Studies (nifekalant hydrochloride) | Trials (nifekalant hydrochloride) | Recent Studies (post-2010) (nifekalant hydrochloride) | Studies (pinacidil) | Trials (pinacidil) | Recent Studies (post-2010) (pinacidil) |
|---|---|---|---|---|---|
| 138 | 16 | 38 | 1,059 | 41 | 125 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Black, SC; Chi, L; Friedrichs, GS; Lucchesi, BR; Manley, PJ | 1 |
1 other study(ies) available for nifekalant hydrochloride and pinacidil
| Article | Year |
|---|---|
Antiarrhythmic agent, MS-551, protects against pinacidil + hypoxia-induced ventricular fibrillation in Langendorff-perfused rabbit isolated heart.
Topics: Animals; Anti-Arrhythmia Agents; Disease Models, Animal; Dogs; Guanidines; Heart; Heart Atria; Hypoxia; In Vitro Techniques; Pinacidil; Pyrimidinones; Rabbits; Vasodilator Agents; Ventricular Fibrillation | 1994 |